| Accession Number: | 0001209191-19-032828 |
| Date: | 2019-05-22 |
| Issuer: | FIBROGEN INC (FGEN) |
| Original Submission Date: |
NEFF THOMAS B
C/O FIBROGEN, INC.
409 ILLINOIS ST.
SAN FRANCISCO, CA 94158
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2019-05-22 | M | 6,834 | a | $2.90 | 2,503,912 | direct | ||
| COMMON STOCK | 2019-05-22 | S | 18,400 | d | $35.73 | 2,485,512 | direct | ||
| COMMON STOCK | 2019-05-22 | S | 1,418 | d | $35.71 | 62,672 | indirect | ||
| COMMON STOCK | 2019-05-23 | M | 6,834 | a | $2.90 | 2,492,346 | direct | ||
| COMMON STOCK | 2019-05-23 | S | 17,300 | d | $35.00 | 2,475,046 | direct | ||
| COMMON STOCK | 2019-05-23 | S | 1,100 | d | $35.25 | 2,473,946 | direct | ||
| COMMON STOCK | 2019-05-23 | S | 1,418 | d | $35.05 | 61,254 | indirect | ||
| COMMON STOCK | 2019-05-22 | 0 | $0.00 | 20,000 | indirect | ||||
| COMMON STOCK | 2019-05-22 | 0 | $0.00 | 60,946 | indirect | f7 |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STOCK OPTION (RIGHT TO BUY) | 2.9 | 2019-05-22 | deemed execution date | M | 6,834 (d) | 2020-06-09 | common stock 6,834 | $2.90 | 266,544 | direct | ||
| STOCK OPTION (RIGHT TO BUY) | 2.9 | 2019-05-23 | deemed execution date | M | 6,834 (d) | 2020-06-09 | common stock 6,834 | $2.90 | 259,710 | direct |
| ID | footnote |
|---|---|
| f1 | shares sold pursuant to a 10b5-1 plan. |
| f2 | the shares were sold at prices ranging from $35.28 to $36.22. the reporting person will provide upon request to the sec, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| f3 | the shares were sold at prices ranging from $35.45 to $36.03. the reporting person will provide upon request to the sec, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| f4 | the shares were sold at prices ranging from $34.23 to $35.22. the reporting person will provide upon request to the sec, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| f5 | the shares were sold at prices ranging from $35.23 to $35.30. the reporting person will provide upon request to the sec, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| f6 | the shares were sold at prices ranging from $34.73 to $35.18. the reporting person will provide upon request to the sec, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| f7 | the shares are held by biogrowth partners, lp. the reporting person is the sole general partner of biogrowth partners, lp and has sole voting and dispositive power over the shares held by biogrowth partners, lp. |
| f8 | fully vested. |
